(Q39889523)

15 September 2017

Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma (English)

1 reference

15 September 2017

1 reference

1 reference

K F D Kuhlmann

1

1 reference

15 September 2017

M A van Geer

2

1 reference

15 September 2017

C T Bakker

3

1 reference

15 September 2017

J E M Dekker

4

1 reference

15 September 2017

M J E Havenga

5

1 reference

15 September 2017

R P J Oude Elferink

6

1 reference

15 September 2017

D J Gouma

7

1 reference

15 September 2017

P J Bosma

8

1 reference

15 September 2017

J G Wesseling

9

1 reference

15 September 2017

30 January 2009

1 reference

15 September 2017

1 reference

15 September 2017

16

1 reference

15 September 2017

7

1 reference

15 September 2017

585-597

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2009.4

15 September 2017

0 references

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Improved adenovirus vectors for infection of cardiovascular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Rapid determination of adenoviral vector titers by quantitative real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and d fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Adenoviral serotypes in gene therapy for esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

CD46 is a cellular receptor for group B adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Adenovirus type 11 uses CD46 as a cellular receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Expression of complement restriction factors (CD46, CD55 & CD59) in head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal cancer correlates with tumor differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

7 January 2021

Hepatocyte suspensions and cultures as tools in experimental carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

7 January 2021

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

7 January 2021

Comparison of five incubation systems for rat liver slices using functional and viability parameters

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

7 January 2021

Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

7 January 2021

The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

7 January 2021

Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

7 January 2021

Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46)

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.4

7 January 2021

Identifiers

DOI

10.1038/CGT.2009.4

1 reference

15 September 2017

1 reference